Lam Research Corporation Announces December Quarter Financial Conference Call
Jan 04, 2017 21:06 pm UTC| Business
FREMONT, Calif., Jan. 04, 2017 -- Lam Research Corporation (Nasdaq:LRCX) today announced that the company will host its quarterly financial conference call and webcast on Wednesday, January 25, beginning at 2:00 p.m....
Ancestry.com LLC Announces Participation in 35th Annual J.P. Morgan Healthcare Conference
Jan 04, 2017 21:06 pm UTC| Business
LEHI, Utah, Jan. 04, 2017 -- Ancestry, the global leader in family history and consumer genomics, today announced its expected participation in the following investor conference: 35th Annual J.P. Morgan Healthcare...
Ancestry.com LLC Announces Participation in 35th Annual J.P. Morgan Healthcare Conference
Jan 04, 2017 21:06 pm UTC| Business
LEHI, Utah, Jan. 04, 2017 -- Ancestry, the global leader in family history and consumer genomics, today announced its expected participation in the following investor conference: 35th Annual J.P. Morgan Healthcare...
Bazaarvoice, Inc. to Present at the 19th Annual Needham Growth Conference
Jan 04, 2017 21:06 pm UTC| Business
AUSTIN, Texas, Jan. 04, 2017 -- Bazaarvoice, Inc. (NASDAQ:BV), which is creating the world's smartest network of active shoppers, brands and retailers, today announced that Gene Austin, Chief Executive Officer, and Jim...
Bazaarvoice, Inc. to Present at the 19th Annual Needham Growth Conference
Jan 04, 2017 21:06 pm UTC| Business
AUSTIN, Texas, Jan. 04, 2017 -- Bazaarvoice, Inc. (NASDAQ:BV), which is creating the world's smartest network of active shoppers, brands and retailers, today announced that Gene Austin, Chief Executive Officer, and Jim...
Jan 04, 2017 21:06 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2017 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...
Jan 04, 2017 21:06 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2017 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...